Watch Chathuranga De Silva, Ph.D., Executive Director, Business Development at BioCentriq in an engaging interview with Alicia Didsbury during the ISCT 2024 Annual Meeting in Vancouver.
In this interview, Chat highlights BioCentriq’s unwavering commitment to excellence, showcasing our recent achievements and proven track record in overcoming complex challenges to deliver impactful results. He also introduces the LEAP™ Advanced Therapy Platform, a comprehensive solution designed to accelerate cell therapy development. By offering standardized yet flexible processes, LEAP™ significantly reduces costs and time-to-clinic for early-phase therapies.
Watch NOW and discover how BioCentriq is shaping the future of advanced therapies!
Ready to talk to us about your project? Contact Us